Idiopathic CD4+ Lymphocytopenia May Be due to Decreased Bone Marrow Clonogenic Capability

Background: Idiopathic CD4+ lymphocytopenia is defined by a stable decrease of CD4+ T cells in the absence of any known cause of immune deficiency. The mechanisms responsible for the immunological impairment are still unknown, but a regenerative failure of hematopoietic stem/progenitor cells has bee...

Full description

Saved in:
Bibliographic Details
Published in:International Archives of Allergy and Immunology 2005-04, Vol.136 (4), p.379-384
Main Authors: Isgrò, Antonella, Sirianni, Maria Caterina, Gramiccioni, Claudia, Mezzaroma, Ivano, Fantauzzi, Alessandra, Aiuti, Fernando
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Bone marrow
Bone Marrow - immunology
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
Immunology
Immunopathology
Interleukin-7 - blood
Male
Medical sciences
Middle Aged
Original Paper
Stem cells
T cell receptors
T-Lymphocytopenia, Idiopathic CD4-Positive - etiology
T-Lymphocytopenia, Idiopathic CD4-Positive - immunology
T-Lymphocytopenia, Idiopathic CD4-Positive - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Idiopathic CD4+ lymphocytopenia is defined by a stable decrease of CD4+ T cells in the absence of any known cause of immune deficiency. The mechanisms responsible for the immunological impairment are still unknown, but a regenerative failure of hematopoietic stem/progenitor cells has been hypothesized. Methods: We evaluated in the bone marrow (BM) of 5 patients with idiopathic CD4+ lymphocytopenia the phenotype of BM progenitor cells, their differentiation capacity with colony-forming cells and long-term culture-initiating cell assays, in parallel with the spontaneous IL-7 production in the patient sera. Results: Compared with controls, a regenerative failure of hematopoietic stem cells has been observed, both in ‘committed’ and in ‘uncommitted’ progenitor cells, despite high IL-7 serum levels. The percentage of phenotypically primitive CD34+CD38–DR+ cells (this includes the lymphoid precursor cells) was decreased, suggesting an involvement of the more primitive BM compartment in the de novo T cell generation. Conclusions: Despite the low number of patients, due to the low incidence of the disease, the decrease of primitive precursors sustains the possibility that diminished stem cell precursors might contribute to the development of CD4+ T cell depletion.
ISSN:1018-2438
1423-0097
1365-2567
DOI:10.1159/000084258